Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors – review of assay methodologies and perspectives

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-0801|29|6|803-834

ISSN： 0269-3879

Source： BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol.29, Iss.6, 2015-06, pp. : 803-834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular endothelial growth factor: A potential target of therapy in neuromyelitis optica?

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 4, 2015-11 ,pp. : 349-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Vascular Endothelial Growth Factor Based on Gold Nanoparticles and Immunoreaction Using Resonance Light Scattering

By Chen Zhanguang  

Plasmonics, Vol. 8, Iss. 2, 2013-06 ,pp. : 605-611

Springer Publishing Company

Access to resources Recommend Favorite

Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 13, Iss. 10, 2010-12 ,pp. : 849-854

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Novel Oxazolo[5,4‐d]pyrimidines as Potent VEGFR‐2 Inhibitors

By  

CHEMISTRY & BIODIVERSITY, Vol. 12, Iss. 4, 2015-04 ,pp. : 528-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, synthesis, and molecular docking of novel indole scaffold‐based VEGFR‐2 inhibitors as targeted anticancer agents

By  

ARCHIV DER PHARMAZIE (ELECTRONIC), Vol. 351, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite